Actively Recruiting
Impact of Body Schema Distortion on Remission and Weight Regain in Anorexia Nervosa
Led by Hospices Civils de Lyon · Updated on 2024-06-04
42
Participants Needed
1
Research Sites
104 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Anorexia nervosa is a predominantly female eating disorder that most often appears in adolescence. The latter leads to strict and voluntary food deprivation for several months or even years. The lifetime prevalence of anorexia is 1.4% in women and 0.2% in men. Ultimately, only half of people treated for anorexia nervosa in adolescence recover, 30% simply improve, 21% suffer from chronic disorders and 5 to 6% die. At the same time, between a quarter and half of patients abandon their current treatment, including during hospitalization. Relapses occur during the evolution of anorexia nervosa. Even more worrying, mortality is highest the year following the patient's discharge from hospital. This appears to be due to somatic complications in more than half of cases (most often cardiac arrest), to suicide in 27% of cases. Researchers are still trying to clarify the mechanisms involved in the emergence and persistence of this disorder. The objective is to obtain more verified and faster cures. However, the obstacles to successful treatment are mainly due to the denial of disorders and thinness. From a neurocognitive perspective, the representation one has of one's body is underpinned by two types of representations, i.e. body image and body schema. It has long been shown that body image is altered in anorexia nervosa. More recently, authors have shown that the distortion of the body representation was however more extensive and also affected the body schema. Patients find themselves too fat despite obvious thinness and move through space as if this were really the case. Worryingly, these distortions in bodyschema seem to persist after therapeutic management. Despite the potential role of body-scheme distortions in maintaining the disorder, as well as the risk of relapse, the difficulties in assessing body-scheme are significant. Indeed, recovery in these pathologies is often determined according to the Body Mass Index, self-declaration and questionnaires evaluating body image, again limiting the verification of the resorption of distortions in the body schema. Investigators have therefore developed the systematic, ergonomic and simplified evaluation of the body schema in patients suffering from anorexia nervosa at the time of diagnosis in an expert center, but also during follow-up evaluations thanks to the use of an evaluation platform of the body schema, i.e. the body in brain platform, developed by the LIP/PC2S laboratory and the SATT Linksium which allows the evaluation of the body schema.
CONDITIONS
Official Title
Impact of Body Schema Distortion on Remission and Weight Regain in Anorexia Nervosa
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patient over 15 years old
- Female gender
- Body mass index (BMI) less than 18.5
- Diagnosis of anorexia nervosa according to DSM V (2013)
- Agreement to participate with signed informed consent (or parental consent if underage)
- Affiliated with or beneficiary of a Social Security plan
You will not qualify if you...
- Adults under legal protection measures (guardianship, curatorship, etc.)
- Participation in another research study that may interfere
- Acute psychiatric comorbidities such as suicidal crisis or delusions
- Not fluent in French
- Pregnant, giving birth, or breastfeeding women
- Persons deprived of liberty by judicial or administrative decision
- Admission to a health or social establishment for reasons other than research
- Current or past psychotic disorders, migraine, epilepsy, balance or vertigo disorders, visual or proprioceptive disorders, or neuromuscular disorders
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Referral Center for Eating Disorders. Neurological Hospital-GH East / Hôpital Neurologique Pierre Wertheimer GHE HCL
Bron, France, 69500
Actively Recruiting
Research Team
L
Lisa FILIPPONE, Neuropsychologist
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
OTHER
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here